Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
Sales | 11,439,000 | 16,609,000 | 16,485,000 | 16,502,000 | 15,462,000 |
Cost of Goods | 1,827,000 | 3,409,000 | 3,571,000 | 3,693,000 | 3,112,000 |
Gross Profit | 9,612,000 | 13,200,000 | 12,914,000 | 12,809,000 | 12,350,000 |
Operating Expenses | 7,699,000 | 9,112,000 | 8,893,000 | 8,864,000 | 10,463,000 |
Operating Income | 1,913,000 | 4,088,000 | 4,021,000 | 3,945,000 | 1,887,000 |
Other Income | -689,000 | -547,000 | -423,000 | -827,000 | -905,000 |
Pre-tax Income | 1,224,000 | 3,541,000 | 3,598,000 | 3,118,000 | 982,000 |
Income Tax | 434,000 | 1,216,000 | 1,077,000 | 894,000 | -2,012,000 |
Net Income Continuous | 790,000 | 2,325,000 | 2,521,000 | 2,224,000 | 2,994,000 |
Net Income Discontinuous | 658,000 | 1,424,000 | 97,000 | 10,000 | -97,000 |
Minority Interests | 9,000 | 11,000 | 8,000 | 12,000 | 7,000 |
Net Income | $1,439,000 | $3,738,000 | $2,610,000 | $2,222,000 | $2,890,000 |
EPS Basic Total Ops | 0.19 | 0.48 | 0.33 | 0.28 | 0.36 |
EPS Basic Continuous Ops | 0.10 | 0.30 | 0.32 | 0.28 | 0.36 |
EPS Basic Discontinuous Ops | 0.09 | 0.18 | 0.01 | 0.00 | -0.01 |
EPS Diluted Total Ops | 0.18 | 0.48 | 0.33 | 0.28 | 0.35 |
EPS Diluted Continuous Ops | 0.09 | 0.30 | 0.32 | 0.28 | 0.37 |
EPS Diluted Discontinuous Ops | 0.09 | 0.18 | 0.01 | 0.00 | -0.01 |
EBITDA(a) | $4,371,000 | $6,303,000 | $6,270,000 | $6,049,000 | $3,793,000 |